Pharma

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Merck and Co., Inc. will hold its second-quarter 2009 sales and earnings conference call with institutional investors and analysts beginning on Tuesday, July. During the call, Richard T. Clark, chairman, president and chief executive officer, Peter N. Kellogg, executive vice president and chief financial officer, and Kenneth C. Frazier, executive vice president and president, Global Human Health, will provide an overview of Merck’s financial performance for the quarter.


Today in Conferences/Meetings...keeping you current

Quality of trials reported as conference abstracts in China: How well are they reported
International Journal of Technology Assessment in Health Care, 11/05/09

User Groups Prove Helpful
HealthDataManagement, 11/03/09

Salix Pharmaceuticals Reviews American Association For The Study Of Liver Diseases Annual Meeting
Salix Pharmaceuticals, 11/03/09

Today in Financial Reports...keeping you current

Nabi Biopharmaceuticals Completes Sale of PentaStaph to GlaxoSmithKline PLC
Nabi Biopharmaceuticals, 11/05/09

CPSI Profits Down, Revenue Up
HealthDataManagement, 11/02/09

Antigenics Reports Third Quarter 2009 Financial Results
Antigenics, 11/05/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address